FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

‘Ghost ships’ ferrying illicit oil have sailed into Trump’s crosshairs

Doctor mysteriously found dead inside Dollar Tree freezer reportedly naked

Terrifying video shows out-of-control MTA bus plowing into cars in the Bronx, injuring 8

Pentagon launches full command investigation into Sen. Mark Kelly over ‘serious misconduct’ allegations

Comer gives Clintons last chance to testify in Epstein inquiry before contempt proceedings

Judge Hannah Dugan’s trial for illegal immigrant escape case begins with FBI agent on the stand

Ilhan Omar lashes out at ‘sick’ Republicans for investigating her alleged marriage to brother

Watch: Announcers Stunned as Irate LeBron James Gets Physical with Referee

DHS arrests ‘worst of the worst’ illegal migrants, including murderers and pedophiles, in weekend operation

Trump sues BBC for $10 billion over Jan. 6 speech edit

Erika Kirk shares update after private in-person meeting with Candace Owens

Police release new video of person of interest in Brown University shooting as manhunt resumes

Opinion: Trump’s Post on Rob Reiner’s Death Was a Massive Misstep, While the Vast Majority of MAGA Posts Got It Exactly Right

DC police accused of manipulating crime stats as federal probe finds thousands of misclassified cases

AOC’s luxury spending binge in Puerto Rico reignites questions about ‘socialist’ brand: ‘Peak hypocrisy’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”